Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell ...

Company now plans to share updated OS and PFS data from first-line pancreatic cancer patients (N = 34) treated with atebimetinib + mGnP in Q3 2025, earlier than prior guidance - ...

Bitcoin's growth trajectory points to $200,000 by 2025, and the potential for BTC price to exceed $1 million in the longer ...

The work now underway is concentrated in the 600 block of North Main Street, right where it hits East Street as it curves in ...

Rigetti Computing stock is up big, but is the run over? Explore the risks and rewards of this quantum computing stock to ...

A $1 billion Gilbert development could kick off construction this year after receiving the final approvals from the town’s ...

The Toluca side Tigres beat are the reigning LIGA MX champions, having dethroned tri-campeones Club América back in the spring. It was a landmark moment for a once-proud club that had fallen on hard ...

Research and development spending rose 14.3% compared to Q2 2024, reflecting a busy clinical pipeline, while the net loss (GAAP) increased to $10.4 million. These 10 stocks could mint the next wave of ...

The sheriff's office proposed budget of more than $225 million includes more than $160 million for personnel costs, $50 million for corrections, $11 million for courts and $2 million for internal ...

Compass Therapeutics' pipeline advances with tovecimig's phase 2 success in cancers. Check out why I reiterate my 'Buy' ...

Expanded strategic partnership with The Scripps Research Institute to advance proof-of-concept studies and further develop its program combining systemic DNase I with CAR T-cell therapies ...

As Cointelegraph reported, Ether price predictions after breaking the critical $4,000 level now go as high as $20,000 for the ...